Literature DB >> 20700784

[Nanomedicine : Magnetic nanoparticles for drug delivery and hyperthermia - new chances for cancer therapy].

C Alexiou1, R Tietze, E Schreiber, S Lyer.   

Abstract

The application of nanotechnology for the treatment, diagnosis, and monitoring of illnesses is summarized under the term nanomedicine. A particularly promising application is attributed to nanoparticular drug delivery systems. The goal of these new carrier systems is the selective enrichment of active substances in diseased tissue structures, an increase in bioavailability, the decrease of the active substance degradation and, above all, the reduction and/or avoidance of unwanted side effects. Apart from numerous nanosystems acting as carriers, the use of iron oxide nanoparticles has to be particularly emphasized. On the one hand, those particles are the carriers of the active substance and, on the other hand, can also be visualized with conventional imaging techniques (x-ray tomography, magnetic resonance imaging), called theranostic. In addition, they can be used for hyperthermia, another important supporting pillar of nanomedicine. Both procedures should lead to a personalized and goal-oriented therapy, which is of special medical and socioeconomic importance in view of the increasing number of cancer patients worldwide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20700784     DOI: 10.1007/s00103-010-1097-9

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  5 in total

1.  [Nanomedicine. Innovative applications in medicine].

Authors:  C Alexiou
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

2.  Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.

Authors:  Christina Janko; Stephan Dürr; Luis E Munoz; Stefan Lyer; Ricardo Chaurio; Rainer Tietze; Sarah von Löhneysen; Christine Schorn; Martin Herrmann; Christoph Alexiou
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

3.  Age modulates Fe3O4 nanoparticles liver toxicity: dose-dependent decrease in mitochondrial respiratory chain complexes activities and coupling in middle-aged as compared to young rats.

Authors:  Yosra Baratli; Anne-Laure Charles; Valérie Wolff; Lotfi Ben Tahar; Leila Smiri; Jamal Bouitbir; Joffrey Zoll; Mohsen Sakly; Cyril Auger; Thomas Vogel; Hafedh Abdelmelek; Olfa Tebourbi; Bernard Geny
Journal:  Biomed Res Int       Date:  2014-05-06       Impact factor: 3.411

4.  Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy.

Authors:  Raghavendra Gowda; Nathan R Jones; Shubhadeep Banerjee; Gavin P Robertson
Journal:  J Nanomed Nanotechnol       Date:  2013-12

5.  Treatment of tumour tissue with radio-frequency hyperthermia (using antibody-carrying nanoparticles).

Authors:  Reza Didarian; Ibrahim Vargel
Journal:  IET Nanobiotechnol       Date:  2021-07-09       Impact factor: 2.050

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.